FDA's Rulemaking To-Do List Includes Dampening Pedigrees, Boosting Electronic Labeling
You may also be interested in...
Drug Sample Distribution Reporting Deadline Extended By FDA
FDA is giving manufacturers six more months to provide HHS with information on the distribution of drug samples as it plans further guidance; the Affordable Care Act mandated that the data be submitted by April 1.
E-Submission Part Of FDA Reg Reform Plan; Alzheimer’s Data Standard About To Debut
Standards for organizing clinical data from research in some major diseases are taking shape as FDA moves to clear a regulatory path that eventually could allow all submissions to be done electronically.
E-Submission Part Of FDA Reg Reform Plan; Alzheimer’s Data Standard About To Debut
Standards for organizing clinical data from research in some major diseases are taking shape as FDA moves to clear a regulatory path that eventually could allow all submissions to be done electronically.